Skip to Content

What type of cancer is Rubraca used to treat?

Medically reviewed by Last updated on Feb 8, 2019.

Official Answer


Rubraca (rucaparib) is used for the treatment of advanced mutant BRCA ovarian cancer.

Rubraca is approved for women who have been treated with two or more chemotherapies and whose tumors have a specific BRCA (BReast CAncer susceptibility) gene mutation as identified by an FDA-approved companion diagnostic test.

BRCA genes normally aid in repairing damaged DNA to prevent tumor development. However, gene mutations of BRCA may lead to certain cancers, including ovarian cancers.

Related Drug Information